Jing Fu

Fourth People's Hospital of Sichuan Province

Also affiliated with Sichuan Provincial Hospital of Traditional Chinese Medicine

MedicineBiochemistry, Genetics and Molecular BiologyDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects”.

Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects

Blood Advances(2023)10.1182/bloodadvances.2021006638

N/A

0.416DataRank · unranked

15 citations

Jing Fu, Christopher J. Walker, Jun Yang, Divaya Bhutani, Rajshekhar Chakraborty +5 more

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Blood(2020)10.1182/blood.2020006334

N/A

0DataRank · unranked

18 citations

Jing Fu, Jun Yang, Huihui Ma, Divaya Bhutani, Markus Y. Mapara +3 more

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

Nature Communications(2023)10.1038/s41467-023-39769-8

N/A

0DataRank · unranked

23 citations

Shirong Li, Huihui Ma, Jun Yang, Gabriel M. Pagnotti, Lewis M. Brown +4 more

GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism

Blood Neoplasia(2025)10.1016/j.bneo.2025.100130

N/A

0DataRank · unranked

1 citations

Josefine Krüger, Guifen Liu, Huihui Ma, Michael Sang Hughes, Rajshekhar Chakraborty +6 more